Search results
• The antiviral drug Paxlovid (ritonavir-boosted nirmatrelvir) and Veklury (remdesivir), are the preferred treatments for eligible adult and pediatric patients with current diagnosis of mild-to-moderate COVID-19 and who are at risk for progression to severe COVID-19.
Jul 7, 2022 · State-licensed pharmacists can now prescribe Paxlovid, Pfizer's COVID-19 antiviral treatment, to people who have been recently infected and are at high risk for severe disease. This update...
Apr 5, 2024 · Key Takeaways. The Food and Drug Administration (FDA) has authorized pharmacists to prescribe Paxlovid to eligible patients who test positive for COVID-19. Patients must connect the pharmacist to a provider who knows their medical history or be able to provide recent kidney and liver function tests.
Mar 25, 2024 · Paxlovid, an oral antiviral pill that can be taken at home, is the go-to treatment for COVID-19. If you are at high risk for severe disease from COVID, and you take it within the first five days of experiencing symptoms, it will lower your risk of getting so sick that you need to be hospitalized.
Walgreens pharmacists can now prescribe Paxlovid to help treat COVID-19. Learn more today and see if you are eligible for the antiviral treatment.
Jan 29, 2024 · [01/29/2024] In December 2021, FDA authorized Paxlovid for emergency use for the treatment of adults and pediatric patients (12 years of age and older weighing at least 40 kg) who are at high...
Aug 5, 2022 · Key Takeaways. Paxlovid is an antiviral medication that can help shorten the course of illness with COVID-19 and prevent serious complications. There are defined parameters for who is eligible for the medication, and it shouldn't be used to treat severe COVID. Experts recommend calling your doctor if you're unsure if you qualify.
